Skip to content

Effectiveness of Mifepristone and Letrozole in medical termination of pregnancy.

Comparison between Letrozole and Mifepristone as pre-treatment in medical management of early pregnancy termination: a prospective open-label randomized controlled trial. - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070965
Enrollment
160
Registered
2024-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O08- Pregnancy with abortive outcome

Interventions

Intervention1: Letrozole: Tablet Letrozole will be given 10 mg once daily per orally for 3 days followed by Tab Misoprostol 800 mcg per vaginally on Day 3 Control Intervention1: Mifepristone: Tab Mife

Sponsors

Sanchari Debnath
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged =18 years and planned for first trimester missed miscarriage with or without vaginal bleeding at 6-9 complete weeks of gestation 2. With a singleton pregnancy. 3. Who agreed to participate in the trial volunterally. 4. Who had no contraindications for medical abortion.

Exclusion criteria

Exclusion criteria: 1.Incomplete or invitable miscarriage defined by the clinical finding of an open cervix with bleeding 2.suspected ectopic pregnancy 3.history of heart liver or kidney disease or adrenal insufficiency abnormal uterine lessons such as adenomyosis fibroid or congenital malformations or intra uterine adhesion 4.pregnancy with an intra uterine contraceptive device in situ 5.history of coagulataory dysfunction or intake of anticoagulant drugs 6.hemoglobin level of less than 9.5 gram

Design outcomes

Secondary

MeasureTime frame
Time interval between consumption of medication and expulsion of product of conceptionTimepoint: 17 days

Primary

MeasureTime frame
Complete evacuation of conceptus Timepoint: 17 days

Countries

India

Contacts

Public ContactDebasis Ray

AGARTALA GOVERNMENT MEDICAL COLLEGE AND GBP HOSPITAL.

iamjlbaidya@hotmail.com9436127555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026